Saltar al contenido
Merck
  • Contribution of mutation at amino acid 45 of AcrR to acrB expression and ciprofloxacin resistance in clinical and veterinary Escherichia coli isolates.

Contribution of mutation at amino acid 45 of AcrR to acrB expression and ciprofloxacin resistance in clinical and veterinary Escherichia coli isolates.

Antimicrobial agents and chemotherapy (2005-09-29)
Mark A Webber, Ashraf Talukder, Laura J V Piddock
RESUMEN

Fluoroquinolone-resistant Escherichia coli isolates which overexpressed acrB and had a substitution at amino acid 45 of AcrR were complemented with wild-type acrR. Complementation led to increased sensitivity to ciprofloxacin and to ethidium bromide, suggesting that mutation at amino acid 45 of AcrR contributes to ciprofloxacin resistance.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Human IgG Fc Control Protein, recombinant protein